Johnson & Johnson Acquires Shockwave Medical

Johnson & Johnson Completes Acquisition of V‑Wave Ltd.

October 9, 2024

Medical Devices

Johnson & Johnson has completed its acquisition of V‑Wave Ltd., adding V‑Wave’s Ventura Interatrial Shunt to the Johnson & Johnson MedTech portfolio. The transaction was accounted for as an asset acquisition and will result in an in‑process R&D charge of approximately $600 million as J&J expands its cardiovascular and heart‑failure capabilities.

Shockwave Medical Acquires Neovasc

January 17, 2023

Medical Devices

Shockwave Medical, a U.S.-based cardiovascular device company, agreed to acquire Canada-based Neovasc for approximately $100 million upfront plus a contingent value right of up to $12 per share tied to regulatory milestones. The acquisition adds the Neovasc Reducer System for refractory angina to Shockwave’s cardiology portfolio and is expected to close subject to customary conditions and shareholder approval.

Johnson & Johnson Acquires Abiomed

December 22, 2022

Medical Devices

Johnson & Johnson completed its acquisition of Abiomed on December 22, 2022, acquiring all outstanding shares for $380.00 per share (approximately $16.6 billion enterprise value) plus a contingent value right. Abiomed will operate as a standalone business within Johnson & Johnson's MedTech segment, expanding J&J's capabilities in high-growth cardiovascular and heart-recovery solutions.

Siemens Healthineers to Acquire Varian Medical Systems

August 2, 2020

Medical Devices

Siemens Healthineers AG has agreed to acquire all shares of Varian Medical Systems, Inc. for USD 177.50 per share, valuing the deal at approximately USD 16.4 billion. The transaction, which aims to create an integrated cancer-care portfolio, is expected to close in H1 2021 subject to Varian shareholder and regulatory approvals.

Investor Consortium Acquires Majority Stake in HistoSonics at $2.25B Valuation

August 10, 2025

Medical Devices

HistoSonics, a University of Michigan spin-out developer of the Edison Histotripsy System, sold a majority stake to a consortium led by K5 Global, Bezos Expeditions and Wellington Management in a transaction valuing the company at $2.25 billion. Other investors included Alpha JWC Ventures, Alpha Wave Ventures and Johnson & Johnson’s JJDC; proceeds will be used to accelerate clinical programs and expand the company’s indications and commercial rollout (CEO Mike Blue will become chairman).

Bluewave Technology Group Acquires J.I.L. Communications

September 14, 2023

Telecommunications

Bluewave Technology Group has acquired J.I.L. Communications, Inc., a Louisville-based telecommunications advisory and management firm; financial terms were not disclosed. The acquisition—Bluewave's fourth this year—adds JIL's network, hybrid cloud and contact-center advisory capabilities and more than 350 active customers (notably in healthcare and manufacturing), strengthening Bluewave's technical capability and presence in Kentucky.